Ateni 100mg Film-coated Tablets

国: アイルランド

言語: 英語

ソース: HPRA (Health Products Regulatory Authority)

即購入

製品の特徴 製品の特徴 (SPC)
15-07-2016

有効成分:

Atenolol

から入手可能:

Generics (UK) Limited

ATCコード:

C07AB; C07AB03

INN(国際名):

Atenolol

投薬量:

100 milligram(s)

医薬品形態:

Film-coated tablet

処方タイプ:

Product subject to prescription which may be renewed (B)

治療領域:

Beta blocking agents, selective; atenolol

認証ステータス:

Not marketed

承認日:

1987-04-09

情報リーフレット

                                Colours
Non-Print
Colours
Date:
Time:
Equate CMYK
with
Dimensions
Main Font
Body Text Size
Min Text Size used
Page Count
No. of colours
Pharma Code
SAP No.
Vendor Job No.
Trackwise Proof No.
Glams Proof No.
Client Market
Keyline/Drawing No.
Barcode Info
Description
Component Type
Affiliate Item Code
Superceded Affiliate Item Code
TrackWise PR No.
MA No.
Packing Site/Printer
Supplier Code
Sign-offs
v1/May 2015
18 May 2016
1/2
13:01
Atenolol 50 mg,100 mg 28
Leaflet
897616
729993
897616
PA0405/019/
001-002
Gerard Labs
LT1730AD
456
N/A
281430
1
1
|reland
N/A
N/A
1
Black
Times New Roman
170 x 480 mm
10.5 Pt
10.5 Pt
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
ATENI 50 MG FILM-COATED TABLETS
ATENI 100 MG FILM-COATED TABLETS
atenolol
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
IN THIS LEAFLET:
1. What Ateni is and what it is used for
2. What you need to know before you
take Ateni
3. How to take Ateni
4. Possible side effects
5. How to store Ateni
6. Contents of the pack and other
information.
1. WHAT ATENI IS AND WHAT IT IS
USED FOR
Ateni contains atenolol which belongs to a
group of medicines called beta-blockers.
Ateni can be used to:
•
Treat high blood pressure (hypertension)
•
Help prevent chest pain (angina)
•
Treat irregular or abnormal rhythms of the
heart (arrhythmias)
•
Protect the heart following a heart attack
during early treatment (myocardial
infraction)
•
Help prevent another heart attack from
happening
It works by making your heart beat more
slowly and with less force.
2. WHAT YOU NEED TO KNOW BEF
                                
                                完全なドキュメントを読む
                                
                            

製品の特徴

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Ateni 100mg Film-coated Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 100 mg atenolol.
For the full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Film-coated tablet.
White film-coated, biconvex tablet, approximately 10 mm in diameter,
marked 'AT100'
on one side and 'G'
on the
reverse.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Atenolol is a beta-adrenoceptor blocking drug indicated for:
hypertension
angina pectoris
cardiac arrhythmias
myocardial infarction: early intervention in the acute phase and late
intervention for long term prophylaxis after
recovery from myocardial infarction
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY
ADULTS
_HYPERTENSION_: Initially 50 mg daily. The full effect of this dose
will usually be seen within 1-2 weeks. If an optimal
response is not achieved the dosage may be increased to 100 mg daily.
A further reduction in blood pressure may be
achieved by combining Ateni with other antihypertensive agents.
_ANGINA PECTORIS_: 100 mg once daily or 50 mg twice daily. It is
unlikely that additional benefit will be gained by
increasing the dose.
_CARDIAC ARRHYTHMIAS_: 50 mg-100 mg daily after having controlled the
arrhythmias with intravenous atenolol.
_EARLY AND LATE INTERVENTION AFTER MYOCARDIAL INFARCTION:_ Oral
treatment with Ateni can be initiated in
haemodynamically stable patients with 50 mg twice daily, and then 100
mg once daily. During the early phase of acute
myocardial infraction, treatment with Ateni should be initiated in
hospital under close monitoring.
Discontinue atenolol if bradycardia and/or hypotension requiring
treatment or any other untoward effects occur.
Ateni 100 mg daily is recommended for long-term prophylaxis of
myocardial infraction.
PAEDIATRIC POPULATION
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_
                                
                                完全なドキュメントを読む
                                
                            

この製品に関連するアラートを検索

ドキュメントの履歴を表示する